Treatment algorithm for myelodysplastic syndromes (personal approach): Predominant severe neutropenia is rare in lower-risk MDS. Supportive treatment with G-CSF and antibiotic/antifungal therapy is warranted if infections occur. HSCT, hematopoietic stem cell transplantation. ATG, antithymocyte globulin; CsA, ciclosporine A; EPO, erythropoietin; G-CSF, granulocyte-colony stimulating factor.